There is evidence suggesting that PEDF can inhibit occlusive thrombus formation by blocking platelet activation and aggregation [16], and it may prevent atherothrombosis in patients with diabetes mellitus by inhibiting the CD40-CD40L axis [117, 118]. The gene discussed is SERPINF1; the disease is diabetes mellitus.